Portfolio company
Elegen
United States · £27.6m raised
Raised
£27.6m
Latest stage
Series B
Rounds recorded
1
Backed by
2 investors
Sectors
About
The company manufactures synthetic DNA using cell-free technology for biopharmaceutical and healthcare customers to develop vaccines and genetic medicines.
SourceFunding history · 1
Similar companies
Ansa Biotechnologies
This company manufactures synthetic DNA using enzymatic synthesis technology for researchers in biological engineering, therapeutics, diagnostics and agriculture.
Evonetix
The company develops a desktop DNA synthesis platform for researchers in synthetic biology and drug development to produce high-fidelity gene sequences.
Artis BioSolutions
The company produces synthetic DNA and manufacturing services for biotechnology and pharmaceutical firms developing genetic medicines and advanced therapies.
Ribbon Bio
This company produces synthetic DNA molecules for research and development customers in the biotechnology and biopharmaceutical sectors.
Twist Bioscience
This company manufactures synthetic DNA on silicon chips for customers in the drug discovery, diagnostics, agriculture, and academic research sectors.
Dinya
Dinya develops enzymatic DNA synthesis technology to provide rapid, custom gene-length DNA sequences for healthcare researchers and pharmaceutical manufacturers.
Molecular Assemblies
This company develops enzymatic DNA synthesis technology to provide long, high-quality oligonucleotides for researchers in synthetic biology, therapeutics, diagnostics and data storage.
Bitrobius Genetics
This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.
